Mayo Clinic CEO announces retirement after nearly a decade at the helm

By Catherine Sturman
President and CEO of Mayo Clinic, Dr John Noseworthy has announced his plans to retire at the end of 2018 after nine years leading the research group...

President and CEO of Mayo Clinic, Dr John Noseworthy has announced his plans to retire at the end of 2018 after nine years leading the research group’s operations and 28 years at the Clinic.

The clinic’s reputation has soared under Dr Noseworthy’s leadership, where it has seen one of the its strongest years with regards to quality and safety, research advancements and clinical practice. It has also completed its $3.76bn, eight-year philanthropic campaign.

“2017 was an extraordinary year for Mayo Clinic, and I look forward to working with our leadership team throughout 2018 to continue to strengthen Mayo Clinic and advance our humanitarian mission,” said Dr Noseworthy.

Mayo’s 2017 annual report, highlights that it has gained over $700mn in income, with a 49% increase in net income from 2016. The clinic has also undergone a significant recruitment drive.

See also

“Dr. Noseworthy’s inspirational and compassionate leadership has guided the organisation from a group of separate clinics and hospitals to a single integrated organisation focused on serving our patients,” added Jeff Bolton, Vice President, Administration, Mayo Clinic.

Samuel Di Piazza, Chair, Mayo Clinic Board of Trustees commented, “During his tenure as CEO, Dr. Noseworthy led Mayo Clinic to focus on key priorities, significantly increase its external visibility and achieve designation as the No. 1 hospital in the nation by U.S. News & World Report in 2016 and 2017.

“Mayo Clinic has consistently advanced its strategic direction under Dr. Noseworthy’s leadership and is well-positioned for continued success in 2018.”

Its new CEO will be announced in August once identified and transition plans are put in place.

Share

Featured Articles

Philips Q1 Results hit by $1.1bn Respironics Settlement

As Royal Philips reports Q1 2024 results we profile the Netherlands-based healthcare technology company, who made the switch from consumer electronics

Vaccine Breakthrough on Antibiotics Resistant Diseases

As researchers report breakthrough on vaccine against MRSA bacteria, we look at which pharmas are working on vaccines to combat antimicrobial resistance

Oracle Fusion Cloud Update Boost for Patients

Oracle Fusion Cloud SCM includes new Healthcare Marketplace solution to help hospitals & clinics optimise planning, automate processes and improve outcomes

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

Sustainability

WHO Health Chatbot Built on 'Humanised' GenAI

Digital Healthcare

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Medical Devices & Pharma